AVITA Medical Announces Exclusive Distribution Agreement with Stedical Scientific AVITA Medical announced exclusive multi-year distribution agreement with Stedical Scientific, Inc. to commercialize PermeaDerm in the United States.

Stedical Scientific continues its mission to accelerate the global distribution of disruptive innovations in healthcare CARLSBAD, Calif. and SHANGHAI, China, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Stedical Scientific announced today that it has secured three new billing codes, which providers may use when treating...

Stedical Scientific unveils stunning results from PermeaDerm® clinical trials at the 2022 Annual Meeting of the American Burn Society CARLSBAD, Calif., April 25, 2022 (GLOBE NEWSWIRE) -- The 54th American Burn Association annual meeting was held in Las Vegas, from April 5 – 8, 2022. As one of the most important academic events in...